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Abstract
Introduction
An increasing number of studies have investigated microRNAs (miRNAs) as potential mark-
ers of diagnosis, treatment and prognosis. So far, agreement between studies has been
minimal, which may in part be explained by intratumoral heterogeneity of miRNA expres-
sion. The aim of the present study was to assess the heterogeneity of a panel of selected
miRNAs in rectal cancer, using two different technical approaches.
Materials and Methods
The expression of the investigated miRNAs was analysed by real-time quantitative polymer-
ase chain reaction (RT-qPCR) and in situ hybridization (ISH) in tumour specimens from 27
patients with T3-4 rectal cancer. From each tumour, tissue from three different luminal loca-
lisations was examined. Inter- and intra-patient variability was assessed by calculating intra-
class correlation coefficients (ICCs). Correlations between RT-qPCR and ISH were
evaluated using Spearman’s correlation.
Results
ICCsingle (one sample from each patient) was higher than 50% for miRNA-21 and miRNA-31.
For miRNA-125b, miRNA-145, and miRNA-630, ICCsingle was lower than 50%. The ICCmean
(mean of three samples from each patient) was higher than 50% for miRNA-21(RT-qPCR
and ISH), miRNA-125b (RT-qPCR and ISH), miRNA-145 (ISH), miRNA-630 (RT-qPCR), and
miRNA-31 (RT-qPCR). For miRNA-145 (RT-qPCR) and miRNA-630 (ISH), ICCmean was
lower than 50%. Spearman correlation coefficients, comparing results obtained by RT-qPCR
and ISH, respectively, ranged from 0.084 to 0.325 for the mean value from each patient, and
from -0.085 to 0.515 in the section including the deepest part of the tumour.
Conclusion
Intratumoral heterogeneity may influence the measurement of miRNA expression and con-
sequently the number of samples needed for representative estimates. Our findings with
PLOS ONE | DOI:10.1371/journal.pone.0156919 June 3, 2016 1 / 13
a11111
OPEN ACCESS
Citation: Eriksen AHM, Andersen RF, Nielsen BS,
Sørensen FB, Appelt AL, Jakobsen A, et al. (2016)
Intratumoral Heterogeneity of MicroRNA Expression
in Rectal Cancer. PLoS ONE 11(6): e0156919.
doi:10.1371/journal.pone.0156919
Editor: Rajvir Dahiya, UCSF / VA Medical Center,
UNITED STATES
Received: March 29, 2016
Accepted: May 20, 2016
Published: June 3, 2016
Copyright: © 2016 Eriksen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The project expenses regarding research
materials were covered by Vejle Hospital Research
Council. The funder did not provide support in the
form of salaries for authors. The Agency of Research
and Innovation provided funding for BSN (Bioneer A/
S). The funding organizations did not play a role in
the study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: BSN is employed by Bioneer
A/S, Denmark, a non-profit company owned by The
two different methods suggest that one sample is sufficient for adequate assessment of
miRNA-21 and miRNA-31, whereas more samples would improve the assessment of
miRNA-125b, miRNA-145, and miRNA-630. Interestingly, we found a poor correlation
between the expression estimates obtained by RT-qPCR and ISH, respectively.
Introduction
MicroRNAs (miRNAs) are short non-coding RNAmolecules acting as negative gene regulators
at the post-transcriptional level. It is well known that the same miRNA may affect several
genes, but also that the same gene may be downregulated by different miRNAs. Thus, miRNAs
represent a complex regulatory system of central biological importance. The system is dysregu-
lated during malignant transformation, and it is generally anticipated that change of miRNA
activity plays a central role in carcinogenesis [1–4]. Consequently, a considerable and increas-
ing number of studies have investigated miRNAs as potential markers of diagnosis, treatment,
and prognosis. The clinical implications, however, have so far been minimal [5]. One reason
may be different methodological approaches, which hampers comparison of studies. Another
issue is the different composition and quality of patient materials investigated. Moreover, the
literature is dominated by many small studies without subsequent validation of relevant find-
ings [5–10].
Another important obstacle is normalisation of real-time quantitative polymerase chain
reaction (RT-qPCR) data, when measuring miRNA expression, as appropriate normalisation is
important to ensure reliable and reproducible results. Despite an increasing number of miRNA
expression studies, the literature is sparse when it comes to reliable normaliser candidates [11–
14].
Intratumoral heterogeneity is a general characteristic of malignant tumours [15–17] and
represents a major obstacle in the study of tumour biology, miRNAs being no exception. To
date, the issue has been almost neglected despite its obvious importance; the activities of miR-
NAs are likely to vary in different parts of the tumour with potential major impact on the clini-
cal application. Only few publications have addressed the problem of intratumoral
heterogeneity affecting the measurement of miRNA expression. One study is dealing with the
issue in breast cancer [18], another one in hepatocellular carcinoma [19].
These challenges are especially relevant in patients with locally advanced rectal cancer,
where treatment decisions are often based on single biopsies and the later interpretation of the
tumour is influenced by the pre-operative radiotherapy [20, 21].
The aim of the present study was to analyse the expression heterogeneity of a panel of
selected miRNAs in rectal cancer specimens by two different technical approaches, and to elu-
cidate their mutual concordance. RT-qPCR was chosen, since it is widely accepted as the gold
standard for miRNA expression analyses. In situ hybridization (ISH) was chosen because of its
ability to visualise the cellular localisation of the investigated miRNAs in addition to the
expression level.
Materials and Methods
Patients and tissue samples
Twenty-seven patients were randomly selected from a cohort of 239 patients who had under-
gone resection for rectal cancer at Vejle Hospital, Denmark from 1999 to 2008. Inclusion was
made only if the histopathological diagnosis was rectal adenocarcinoma pT3 or pT4, if no pre-
operative chemo-radiotherapy was given, and if formalin-fixed paraffin-embedded (FFPE)
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rectal cancer tissue was available from three different localisations of the tumour, including the
luminal aspect.
According to The Regional Scientific Ethical Committees for Southern Denmark, ethics
approval and written informed consent were not required, since the purpose of the study was
to develop new methodology and no clinical data were further analysed (Act on Research Eth-
ics Review of Health Research Projects, cf. § 14, section 1). The samples were collected during
standard rectal resection, and the project was carried out without knowledge of the clinical
data. The study was registered with The Danish Data Protection Agency, and The Danish Reg-
istry of Human Tissue Utilisation was consulted before any tissue samples were used.
Available histological sections stained with hematoxylin and eosin (H&E) were examined
by a pathologist in order to select three localisations from each tumour. The sections had to be
cut from tissue blocks sampled from three different localisations, and all had to include the
luminal aspects of the tumour mirroring the locations where diagnostic, endoscopic biopsies
would have been taken. According to this selection, adjacent sections were cut from each of the
FFPE tissue blocks for the heterogeneity analyses as follows: (a) one section to be stained with
H&E for identification of Region of Interest (ROI), (b) four sections for ISH (5 μm), (c) two
sections to be stained with hematoxylin for RT-qPCR (8 μm), (d) one look-up section to be
stained with H&E. On a print of the H&E stained section, tumour and tumour microenviron-
ment were identified by the pathologist and encircled as regions of interest (ROI). Subse-
quently, the marking was transferred to the digital whole slide image of the ISH-slide, and to
the H&E stained section and the hematoxylin stained section for RT-qPCR. For the RT-qPCR-
analysis, the marked area was removed using a scalpel and collected in 1.5 ml RNase-free PCR
tubes containing a drop of ethanol (99%) (S1 and S2 Figs).
Target miRNAs and normaliser miRNAs
Five target miRNAs were chosen based on the literature searches: miRNA-21 based on its well-
known up-regulation in colorectal cancer (CRC) and suggested down-regulation after neo-
adjuvant chemo-radiotherapy [6, 9, 22]; miRNA-31 based on the positive correlation between
expression level and stage of CRC [4, 23]; miRNA-125b, miRNA-145, and miRNA-630 based
on their suggested up-regulation in rectal cancer tissue after neo-adjuvant chemo-radiotherapy
[6–8].
Addressing the question of normalisation we recently performed a study on miRNA expres-
sion profiling to identify and validate reference genes for relative quantification of miRNAs.
MicroRNA-193a-5p, miRNA-27a, and let-7g were identified as the most stably expressed miR-
NAs in our cohort of rectal cancer and were consequently used as normalisers in the present
study [24].
Expression analysis by RT-qPCR
RNA extraction. RNA was isolated from the micro dissected FFPE tissue using the miR-
Neasy FFPE Kit (Qiagen, Germany) according to the manufacturer’s instructions. First step
was adding a lysis buffer containing proteinase K followed by a short incubation at 70°C. This
was followed by DNase treatment and RBC buffer treatment. Ethanol was added and the sam-
ple was applied to an RNeasy MinElute spin column, where the total RNA, including miRNA,
was bound to the membrane. Finally, total RNA was eluted in 14 μl RNase-free water.
RT-qPCR. The Custom TaqMan1MicroRNA Single Assays (Life Technologies, CA,
USA) for hsa-let-7g 002282, hsa-miR-193a-5p 002281, hsa-miR-27a 000408, hsa-miR-21
000397, hsa-miR-31 002279, hsa-miR-125b 000449, hsa-miR-145 002278, and hsa-miR-630
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001563 were used according to the manufacturer’s standard instructions for low sample input
(LSI).
CustomMicroRNA RT Primer Pool and CustomMicroRNA PreAmp Primer Pool for ana-
lysing the above mentioned miRNAs were created according to Protocol for Creating Custom
RT and Preamplification Pools using TaqMan1MicroRNA Assays (Publication Part Number
4465407, Life Technologies).
RNA was reverse-transcribed using the CustomMicroRNA RT Primer Pool. Each RT reac-
tion contained 3 μl total RNA and 12 μl RT reaction mix from TaqMan1MicroRNA Reverse
Transcription Kit.
Preamplification (12 cycles) was performed with the CustomMicroRNA PreAmp Primer
Pool, each reaction containing 2.5 μl RT Product, TaqMan1 PreAmp Master Mix (2X) and
PreAmp Primer Pool in a total reaction volume of 25 μl. The PreAmp Product was diluted 1:40
in TE buffer.
The RT-qPCR analyses were carried out on Applied Biosystems 7900 HT Real-Time System
using 1 μl diluted PreAmp product, TaqMan1MicroRNA Assays and TaqMan1 Universal
Master Mix II NoAmpErase1 UNG in a total reaction volume of 20 μl. All reactions were per-
formed in triplicate. Data analysis was performed using SDS software ver. 2.2.2 (Life
Technologies).
Water was used as negative control. The no template control was included in the entire pro-
cess (RT, preamplification and qPCR) and analysed together with samples.
Relative quantification. Average values of triplicate Cq values were used for further analy-
sis. Cq is defined as the PCR cycle number at which the fluorescence meets the threshold in the
amplification plot. The arithmetic mean of Cq values for miRNA-193a-5p, miRNA-27a, and
let-7g was used for normalisation as mentioned above.
ΔCq values were converted to linear values for statistical analyses by the equation linear
value (ΔCq) = 2-ΔCq assuming that the amplification efficiency of the assays was close to 100%.
Expression analysis by in situ hybridization
Prior to the analysis, assay optimisation was accomplished to determine optimal probe concen-
trations and hybridization temperatures. MicroRNA-31 was not detected in 10 samples ana-
lysed during assay optimisation and was therefore not further explored. ISH for miRNA-21,
miRNA-125b, miRNA-145, and miRNA-630 was performed as previously described [25] using
the following concentrations: 20nM (miRNA-21 and miRNA-145), 30nM (miRNA-630),
50nM (miRNA-125b). The ISH analysis was performed using a Tecan Freedom Evo automated
hybridization instrument (Tecan, Switzerland), in which the following steps were performed:
pre-digestion with proteinase-K (15 μg/ml) at 37°C for 8 minutes, pre-hybridization at 57°C
for 15 minutes, hybridization with double-carboxyfluorescein (FAM) labelled Locked Nucleic
Acid (LNA) probes (Exiqon A/S, Denmark) for 1 hour. The miRNA-125b was processed at
56°C. After stringent washes with saline-sodium-citrate buffer the probes were detected with
alkaline phosphatase-conjugated sheep anti-FAM Fab fragments, followed by incubation in
4-nitroblue tetrazolium and 5-bromo-4-chloro-3’-indolylphosphate (Roche, Denmark) for 60
minutes (90 minutes for miRNA-125b) resulting in a dark blue staining, and finally counter-
staining with nuclear fast red (Vector Laboratories, CA, USA).
Image analysis and quantification
Digital whole slide images were obtained with an x20 objective using an Axio Scan Z1 bright
field scanner (Carl Zeiss, Germany). Image analysis of the digital slides was performed using
VisiomorphDP software (Visiopharm, Denmark).
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The areas of ROI encircled on the H&E stained sections were outlined on the ISH digital
whole slide images, and staining artefacts as well as tissue artefacts were cleared. Some slides
were in a poor condition caused by folded or lost tissue, which limited the size of the area
included in the ROI. We found, not surprisingly, that images with a small ROI (less than 2
mm2) contributed with quite dramatic variation and they were therefore omitted from the sta-
tistical analyses. For miRNA-21 five patients were excluded; for miRNA-125b and miRNA-630
three patients were excluded; and for miRNA-145 four patients were excluded.
A pixel classifier was trained to discriminate the blue ISH signal from the red counterstain,
the unstained and weakly stained tissue, and the tissue-free areas. The following parameters
were obtained during image processing from each ROI: area of intense blue (the ISH signal),
area of weak blue (considered background ISH signal), area of purple blue (blue located over
nuclear red), and the total area of the individual ROIs. The relative area fractions (areas of blue
colour of interest divided by the total ROI area) were considered representative of the relative
expression of the miRNA of interest.
Data analysis
All data were summarised using standard descriptive statistics. Inter- and intra-patient vari-
ability was assessed by calculation of intraclass correlation coefficients (ICC), using a one-way
random-effects model. Specifically, the ICC may in this setting be regarded as the percentage of
the total variance in the samples accounted for by differences between the patients examined. If
the majority of variation in the sample measurements is from inter-patient variation, the ICC
is high (ICC! 1). If the majority of variation is from intra-patient variation, the ICC is low
(ICC! 0). We considered ICC both for single samples (ICCsingle) and for the mean of samples
within patients (ICCmean). The ICCsingle provides an estimate of the reliability of a given sample
as to rendering information about the specific patient (compared to all other patients). Corre-
spondingly, the ICCmean estimates the reliability of the information rendered by taking the
mean of three samples from a patient.
The correlation between RT-qPCR and ISH-fractions for each miRNA was estimated for
individual samples and for mean values for individual patients using the Spearman correlation
coefficient.
In order to illustrate the inter- and intra-patient variation as well as the correlation between
RT-qPCR and ISH values, all data were normalised to allow for plotting on a common scale.
For each miRNA, the mean and the standard deviation for all RT-qPCR measurements of each
patient were calculated, and any individual sample measurement was normalised to a standard
scale by extracting the mean and dividing it by the standard deviation. This was also done for
all ISH measurements, for each miRNA. The resulting values for both RT-qPCR and ISH were
plotted separately for each miRNA.
Results
RT-qPCR
The expression pattern of the target miRNAs (miRNA-21, miRNA-31, miRNA-125b, miRNA-
145, and miRNA-630) was analysed in three different samples from each tumour specimen by
RT-qPCR. MicroRNA-21, miRNA-31, miRNA-125b, and miRNA-145 showed different and
measureable expression levels, and all of the miRNAs were expressed in all three samples from
each tumour. MicroRNA-630 was undetected in two samples from two different patients. The
range of raw Cq levels was 17.4–21.6 for miRNA-21, 20.9–28.7 for miRNA-31, 20.4–26.3 for
miRNA-125b, 15.9–24.4 for miRNA-145, and 28.5–36.7 for miRNA-630. A few outliers of the
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triplicate RT-qPCR measurements were removed from the dataset before further analyses.
After normalisation, the ΔCq values were converted to linear values for further analysis.
In situ hybridization
Relative expression estimates for the target miRNAs (miRNA-21, miRNA-125b, miRNA-145,
and miRNA-630) were obtained by image analysis of the ISH-stained slides (Table 1).The
miRNA-21 ISH resulted in a strong signal in the stromal tissue surrounding the epithelial
tumour cells as also described previously [25, 26]. A strong signal in enteric neurons in the
stromal tissue and a weaker signal in other stromal cells were detected for miRNA-125b. The
ISH for miRNA-145 resulted in a strong and a weak signal mainly in the smooth muscle cells
and myofibroblastic cells surrounding the tumour cells [26, 27]. The miRNA-630 ISH showed
staining of tumour cells and a subset of the adjacent stromal cells. Both strong and weak ISH
signals were considered in the image analysis. Examples of the ISH signals for miRNA-21,
miRNA-125b, miRNA-145, and miRNA-630 with the corresponding classified images are
shown in Fig 1.
Intraclass correlation coefficient (ICC)
The ICC of each miRNA was calculated for both RT-qPCR and ISH as shown in Table 2. For
miRNA-21, miRNA-145, and miRNA-630, the TBp-fraction (i.e. all blue colours) was used,
but for miRNA-125b we did not include the areas with intense blue staining representing the
enteric neurons.
Correlation between qPCR and ISH
The Spearman Correlation Coefficient was calculated to compare the results obtained by RT-
qPCR and ISH, respectively (Table 3). For ISH, when comparing with the RT-qPCR, the TBp-
fraction (all blue colours) was used for all four miRNAs, since RT-qPCR measures the total
expression of the miRNA of interest, regardless of localisation. In general, there was a poor cor-
relation between the estimates obtained by the two techniques with correlation coefficients
ranging from 0.084 to 0.325 for the mean value for each patient, and ranging from -0.085 to
0.515 in the section including the deepest part of each tumour.
Table 1. In situ hybridization (ISH) for miRNA-21, miRNA-125b, miRNA-145, andmiRNA-630: Classifiers, relative area fractions and localisation of
ISH signal.
Classiﬁer (ISH signal) Area fraction Localisation of ISH signal
miRNA-21 TBp* 0.0091–0.5751 Stromal cells
miRNA-125b TBp 0.0004–0.0848 Stromal cells
iB** 0.0000–0.0030 Enteric neurons in stroma
wpB*** 0.0004–0.0818 Other stromal cells
miRNA-145 TBp 0.0002–0.1141 Smooth muscle cells
miRNA-630 TBp 0.0012–0.1302 Tumour cells and stromal cells
Intense blue (iB) represents the strong ISH signal, weak blue (wB) the background ISH signal, and purple blue (pB) the blue located over nuclear red.
* TBp (all blue colours) = iB + wB + pB
** For miRNA-125b, iB represents enteric neurons in the stromal tissue. They were present regardless of cancer and were excluded from the ICC
analysis.
*** wpB = TBp—iB; used for calculating the ICC for miRNA-125b.
doi:10.1371/journal.pone.0156919.t001
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The intra- and inter-patient variation and the correlation between RT-qPCR and ISH for
miRNA-21, miRNA-125b, miRNA-145, and miRNA-630 are illustrated in Fig 2. For miRNA-
31 (RT-qPCR, only) see S3 Fig.
Discussion
An increasing number of studies focus on miRNAs as potential biomarkers in cancer diagnosis
and treatment, but the divergent and contradicting results in the literature are a major obstacle
to clinical application [5, 21]. The situation calls for a critical approach to methodological
aspects among which heterogeneity ranks high.
Tissue heterogeneity is a general characteristic of malignant tumours. It is well known that
the micro-environment varies throughout the tumour with effect on growth, proliferation, and
metastatic potential. The behaviour of tumour mutations is inconsistent, too [16, 17].
Fig 1. In situ hybridization (ISH) visualizing the expression of miRNA-21, miRNA-125b, miRNA-145,
andmiRNA-630 in rectal cancer tissue. The ISH signal is corresponding to the blue colour in the left row.
St: stroma; Ca: epithelial tumor cells. (A) Expression of miRNA-21 mainly present in the stroma adjacent to
the epithelial tumour cells. (B) Pixel classifier corresponding to image A. (C) Expression of miRNA-125b with
strong ISH-signal present in an enteric neuron (arrows) and weaker ISH signal representing different stromal
cells. (D) Pixel classifier corresponding to image C. (E) Expression of miRNA-145 mainly present in smooth
muscle cells (SMC) and myofibroblastic cells. (F) Pixel classifier corresponding to image E. (G) Expression of
miRNA-630 scattered in epithelial tumour cells and adjacent stromal cells (arrows indicate examples of ISH-
positive cells in the stroma). (H) Pixel classifier corresponding to image G.
doi:10.1371/journal.pone.0156919.g001
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Consequently, the issue holds crucial importance in biomarker research with perspectives of
clinical application. This also applies to miRNAs. The present study addressed the heterogene-
ity problem comparing two different methods of miRNA expression analysis.
The literature dealing with miRNA and intratumoral heterogeneity is sparse. Raychaudhuri
et al. (2012) investigated intratumoral heterogeneity of a panel of miRNAs in breast cancer
[18] by RT-qPCR. They found a coefficient of variation (CV) of 40% within primary tumour
samples and conclude that, intratumoral heterogeneity can lead to significant sampling bias
and, assessment of miRNA profiles may require sampling at several different tumour locations.
Peveling-Oberhag et al. (2014) [19] performed a miRNA profiling in hepatocellular carcinoma
comparing different compartments of liver tumours and found that the miRNA dysregulation
varies within tumour compartments. The two studies cannot without reservation be compared
with our results, as none of them report the ICC. On the other hand, they both report signifi-
cant intratumoral heterogeneity in accordance with the present study.
To the best of our knowledge, this is the first study to assess the intratumoral heterogeneity
of miRNAs in rectal cancer. Moreover, we are not aware of any other studies applying the two
techniques of RT-qPCR and ISH on adjacent sections of tissue to elucidate their mutual con-
cordance. RT-qPCR was chosen, since it is widely accepted as the gold standard for miRNA
expression analyses. ISH was chosen because of its ability to visualise the cellular localisation of
the investigated miRNA in addition to the expression level. We used tumour specimens from
Table 2. Intraclass Correlation Coefficient (ICC) for one sample from each tumour (ICCsingle) and for
three different samples from each tumour (ICCmean) as obtained by RT-qPCR and ISH.
Method ICC (single) ICC (mean)
miRNA-21 PCR 0.650 0.848
ISH 0.632 0.838
miRNA-125b PCR 0.453 0.713
ISH 0.281 0.540
miRNA-145 PCR 0.134 0.317
ISH 0.264 0.518
miRNA-630 PCR 0.284 0.543
ISH 0.222 0.461
miRNA-31 PCR 0.782 0.915
The ICCsingle was higher than 50% for miRNA-21 (RT-qPCR: 65%, ISH: 63%) and miRNA-31 (RT-qPCR:
78%), and for miRNA-125b, miRNA-145, and miRNA-630, it was lower than 50%.
As to ICCmean it was higher than 50% for miRNA-21(RT-qPCR and ISH), miRNA-125b (RT-qPCR and
ISH), miRNA-145 (ISH), miRNA-630 (RT-qPCR), and miRNA-31 (RT-qPCR) and lower than 50% for
miRNA-145 (RT-qPCR) and miRNA-630 (ISH). As shown in Table 2, the ICCmean is generally higher than
the ICCsingle.
doi:10.1371/journal.pone.0156919.t002
Table 3. Spearman Correlation Coefficients comparing RT-qPCR and ISH for averagemeasures for
individual patients and for a single sample from each patient (the one of the three sections including
the deepest part of the tumour).
Spearman Correlation (mean) Spearman Correlation (deepest section)
miRNA-21 0.158 0.294
miRNA-125b 0.084 -0.085
miRNA-145 0.273 0.312
miRNA-630 0.325 0.515
doi:10.1371/journal.pone.0156919.t003
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patients with rectal cancer to analyse the intratumoral heterogeneity of a panel of miRNAs
with potential clinical relevance [4, 6–9, 22, 23].
We found the overall extent of heterogeneity, as expressed by ICC, to be different for the
five miRNAs. The CV is not as useful a parameter in this setting, as it does not provide a direct
measure of the intra-patient variation relative to the overall variation in the measurements.
The ICC, however, allows for comparison of the intra- and inter-patient variation in the data-
sets from the two different methods, thus providing an estimate of the precision of the individ-
ual measurements referring to a specific patient.
The inter-patient variation was higher than that of the intra-patient variation with respect
to miRNA-21 and miRNA-31. This is an indication that the two miRNAs have potential as bio-
markers, when analysing one sample (e.g. one diagnostic biopsy). Here we found that mean
ICC values for RT-qPCR and ISH were almost identical for miRNA-21, 0.848 and 0.838,
Fig 2. Inter- and intra-patient variation and correlation between RT-qPCR and ISHmeasurements for miRNA-21, miRNA-125b, miRNA-145, and
miRNA-630. All data were normalised to be plotted on a common scale: see the main text for details. Each vertical line represents the range of the three
measures obtained in the individual patient with different colours to represent RT-qPCR and ISHmeasurements, respectively. For each miRNA, patients
were sorted according to their mean RT-qPCRmeasurement for plotting.
doi:10.1371/journal.pone.0156919.g002
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respectively. These values are in good concordance with Nielsen et al. (2011), who reported an
ICC value for miRNA-21 ISH of 84% in CRC tissue [25].
On the other hand, for miRNA-125b, miRNA-145, and miRNA-630, the ICCsingle was
below 50%, requiring more cautiousness when interpreting results from a single sample. For
miRNA-125b and miRNA-630 the ISH analysis showed lower ICC values (single and mean)
than the RT-qPCR analysis, indicating a higher intra-patient variation for the ISH analysis. For
miRNA-145 it was an opposite scenario with the ISH analysis showing higher ICC values (sin-
gle and mean) than the RT-qPCR analysis, indicating a higher intra-patient variation for the
RT-qPCR analysis. Therefore, relying only on the ICCs, none of the two techniques are supe-
rior to the other.
Interestingly, we found a poor correlation between the results from RT-qPCR and ISH for
all the miRNAs; so even though ICC (single and mean) is equal for RT-PCR and ISH for
miRNA-21, the results are not comparable. The main explanation is likely to be inherent differ-
ences in the methodology of RT-qPCR and ISH. E.g. different from the RT-qPCR technique,
the ISH technique detects both precursor and mature miRNAs. However, it cannot be excluded
that part of an explanation for the poor correlation could be small displacements of ROI when
copying it from the primary plotting to the ISH digital whole slide image and to the slide for
RT-qPCR. This would mean a difference in the analysed area, especially in the stroma, where
all the miRNAs are represented.
In general, RT-qPCR has a high reproducibility and is a relatively low cost method applica-
ble in most laboratories. FFPE tissue is well suited for miRNA expression analysis performed
on a small amount of tissue with only the mature miRNAs being detected. However, RT-qPCR
includes several preparatory steps (RNA extraction, reverse transcription, preamplification) in
which technical variation can be introduced, and in addition proper normalisation is essential
to ensure reproducible results.
The ISH technique presents several advantages, including the ability to visualise the cellular
localisation of the investigated miRNAs in addition to the expression level. The quantitative
ISH method requires standardised section thickness, because the quantitative estimates are not
normalised against a reference standard. Other preparatory steps that may introduce some
technical variation include proteolytic pre-treatment as well as tissue folds and detachment. In
addition, ISH is a more laborious method not suitable for all laboratories, and data interpreta-
tion requires specialised staff
In the present study it was possible to visualise the cellular localisation of the investigated
miRNAs, and the corresponding ISH signal allowed for focus on the relevant cells in the ISH
data analysis. For miRNA-125b we could leave out the strong ISH signal form the enteric neu-
rons when calculating the ICC. For RT-qPCR, the same option is not available, and miRNA-
125b from the enteric neurons is a part of the measured expression level. Since the enteric neu-
rons are present regardless of cancer, leaving them out of the analysis would be the most accu-
rate thing to do. In that case, RT-qPCR including miRNA-125b from the enteric neurons
would give a biased estimate, and ISH would probably give a more correct result. This has to be
balanced with the loss of cases in the ISH analyses due to folded or lost tissue. Thus, several
cases were actually lost for all the analysed miRNAs, probably due to erroneous fixation of the
tumours.
For all miRNAs ICCmean was higher than ICCsingle. A low ICC value could be explained as a
high measurement noise, whereas a high ICC value indicates less measurement noise. The fact
that ICCmean was higher than ICCsingle suggests that pooling all three samples reduces the mea-
surement noise, but only one available biopsy is often the scenario in clinical practice.
Relying on the ICCs calculated here, it was not possible to conclude which of the two tech-
niques, RT-qPCR or ISH, provides the most representative expression estimates and thereby
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comprise the tumour heterogeneity. However, for clinical application of a method, practical
factors such as number of biopsies needed for examination, accessibility and cost of the
method, and interpretation of the results are indeed important factors
In conclusion, intratumoral heterogeneity should be considered in the analysis of miRNAs
as biomarkers, and miRNA analysis should hence be performed on all available samples. One
sample may be sufficient in some settings as indicated for miRNA-21 and miRNA-31 in the
current study. The poor correlation between RT-qPCR and ISH suggests that results obtained
by the two techniques should be compared with caution. In a clinical setting, RT-qPCR seems
preferable as an easy method of getting reproducible results, however, it cannot be excluded
that the ISH method may provide more clinically relevant expression estimates.
Supporting Information
S1 Fig. Rectal cancer specimen for miRNA expression analyses. (A) From the superficial /
luminal part of the tumour, three different locations (red arrows) were chosen for examination.
(B) The sections for RT-qPCR and ISH were cut at the same time as adjacent sections. The
Region of Interest (ROI) was encircled on a print of the digital whole slide image of the HE-sec-
tion. ROI was transferred to the digital whole slides of the ISH-images and to the sections cut
for RT-qPCR.
(TIF)
S2 Fig. Region of Interest (ROI). (A) On a print of the H&E stained section, ROI was marked
by the pathologist. (B) The marking was transferred to the sections stained with both hematox-
ylin and eosin / stained with hematoxylin only.
(TIF)
S3 Fig. Inter- and intra-patient variation for miRNA-31(RT-qPCR only). Data were nor-
malised for plotting on a common scale. For any given measurement, the mean and the stan-
dard deviation for that measurement for all samples were calculated, and any individual data
point was normalised to a standard scale by extracting the mean and dividing it by the standard
deviation. The resulting values for RT-qPCR were plotted for each patient.
(EPS)
S1 Table. Data from the RT-qPCR analysis.
(XLSX)
S2 Table. Data from the ISH image analysis.
(XLSX)
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